Literature DB >> 35166421

HP1 maintains protein stability of H3K9 methyltransferases and demethylases.

Ryo Maeda1,2, Makoto Tachibana1,2.   

Abstract

Di- or tri-methylated H3K9 (H3K9me2/3) is an epigenetic mark of heterochromatin. Heterochromatin protein 1 (HP1) specifically recognizes H3K9me2/3, contributing to transcriptional suppression and spread of H3K9me2/3. Here, we demonstrate another role of HP1 in heterochromatin organization: regulation of protein stability of H3K9 methyltransferases (H3K9 MTs) and demethylases (H3K9 DMs). We show that HP1 interaction-defective mutants of H3K9 MTs, Suv39h1 and Setdb1, undergo protein degradation. We further establish mouse embryonic stem cell lines lacking all three HP1 paralogs. In the HP1-deficient cells, Suv39h1, Suv39h2, Setdb1, and G9a/GLP complex decrease at the protein level, and the enzymes are released from chromatin. HP1 mutants that cannot recognize H3K9me2/3 or form dimers cannot stabilize these enzymes, indicating that the tethering of H3K9 MTs to chromatin is critical for their protein stability. We show that HP1 also stabilizes H3K9 DMs, Jmjd1a and Jmjd1b. Our study indicates that mammalian HP1 forms a heterochromatin hub that governs protein stability of H3K9 MTs and H3K9 DMs.
© 2022 The Authors.

Entities:  

Keywords:  H3K9 demethylase; H3K9 methyltransferase; H3K9me2/3; HP1; heterochromatin

Mesh:

Substances:

Year:  2022        PMID: 35166421      PMCID: PMC8982598          DOI: 10.15252/embr.202153581

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  56 in total

1.  Structural basis of HP1/PXVXL motif peptide interactions and HP1 localisation to heterochromatin.

Authors:  Abarna Thiru; Daniel Nietlispach; Helen R Mott; Mitsuru Okuwaki; Debbie Lyon; Peter R Nielsen; Miriam Hirshberg; Alain Verreault; Natalia V Murzina; Ernest D Laue
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

2.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.

Authors:  A J Bannister; P Zegerman; J F Partridge; E A Miska; J O Thomas; R C Allshire; T Kouzarides
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

3.  Dimerisation of a chromo shadow domain and distinctions from the chromodomain as revealed by structural analysis.

Authors:  N P Cowieson; J F Partridge; R C Allshire; P J McLaughlin
Journal:  Curr Biol       Date:  2000-05-04       Impact factor: 10.834

4.  Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31.

Authors:  L Aagaard; G Laible; P Selenko; M Schmid; R Dorn; G Schotta; S Kuhfittig; A Wolf; A Lebersorger; P B Singh; G Reuter; T Jenuwein
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

5.  Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9.

Authors:  Makoto Tachibana; Jun Ueda; Mikiko Fukuda; Naoki Takeda; Tsutomu Ohta; Hiroko Iwanari; Toshiko Sakihama; Tatsuhiko Kodama; Takao Hamakubo; Yoichi Shinkai
Journal:  Genes Dev       Date:  2005-03-17       Impact factor: 11.361

6.  Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3.

Authors:  M Tachibana; K Sugimoto; T Fukushima; Y Shinkai
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

7.  E3-Independent Constitutive Monoubiquitination Complements Histone Methyltransferase Activity of SETDB1.

Authors:  Lidong Sun; Jia Fang
Journal:  Mol Cell       Date:  2016-05-26       Impact factor: 17.970

8.  JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor.

Authors:  Kenichi Yamane; Charalambos Toumazou; Yu-ichi Tsukada; Hediye Erdjument-Bromage; Paul Tempst; Jiemin Wong; Yi Zhang
Journal:  Cell       Date:  2006-04-06       Impact factor: 41.582

9.  Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET.

Authors:  Toshiyuki Matsui; Danny Leung; Hiroki Miyashita; Irina A Maksakova; Hitoshi Miyachi; Hiroshi Kimura; Makoto Tachibana; Matthew C Lorincz; Yoichi Shinkai
Journal:  Nature       Date:  2010-02-17       Impact factor: 49.962

10.  Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia.

Authors:  Kayla A Chase; David P Gavin; Alessandro Guidotti; Rajiv P Sharma
Journal:  Schizophr Res       Date:  2013-06-28       Impact factor: 4.939

View more
  2 in total

1.  HP1 maintains protein stability of H3K9 methyltransferases and demethylases.

Authors:  Ryo Maeda; Makoto Tachibana
Journal:  EMBO Rep       Date:  2022-02-15       Impact factor: 8.807

2.  New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.

Authors:  Leticia Colyn; Gloria Alvarez-Sola; M Ujue Latasa; Carmen Berasain; Maite G Fernandez-Barrena; Matias A Avila; Iker Uriarte; Jose M Herranz; Maria Arechederra; George Vlachogiannis; Colin Rae; Antonio Pineda-Lucena; Andrea Casadei-Gardini; Federica Pedica; Luca Aldrighetti; Angeles López-López; Angeles López-Gonzálvez; Coral Barbas; Sergio Ciordia; Sebastiaan M Van Liempd; Juan M Falcón-Pérez; Jesus Urman; Bruno Sangro; Silve Vicent; Maria J Iraburu; Felipe Prosper; Leonard J Nelson; Jesus M Banales; Maria Luz Martinez-Chantar; Jose J G Marin; Chiara Braconi; Christian Trautwein; Fernando J Corrales; F Javier Cubero
Journal:  J Exp Clin Cancer Res       Date:  2022-05-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.